NHS National Framework for Transition products commencing 1 October 2024
Details
- Buyer
- NHS England
- Value
- £131,960,000
- Topic
- Pharmaceutical products
- Published
- 26 June 2024
- Submission
- 29 July 2024
- Source
- uk:find_a_tender
Tender description
Project title: NHS National Framework for Transition products commencing 1 October 2024<br/>Offer reference number: CM/TNS/24/5712<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.<br/>Potential periods of call-offs under the framework agreement:<br/> <br/>CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) <br/><br/>CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) <br/><br/>Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England Lot 1: CM/TNS/24/5712/01 CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) Additional information: CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) Lot 2: CM/TNS/24/5712/02 CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) Additional information: CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) Lot 1: CM/TNS/24/5712/01 CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) Additional information: CM/TNS/24/5712/01 - Amphotericin liposomal Injection, bexarotene capsules, dabigatran capsules, plerixafor injection and rivaroxaban tablets<br/>Lot 1 CESW: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 2 NWLN: 01/10/2024 to 30/09/2025 (12 months) <br/>Lot 3 LSNE: 01/10/2024 to 31/05/2026 (20 months) Lot 2: CM/TNS/24/5712/02 CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months) Additional information: CM/TNS/24/5712/02 - Imatinib<br/>Lot 1 DSW: 01/10/2024 to 30/09/2025 (12 months)
Timeline
- Completed: Tender published26 June 2024Current notice
- Completed: Submission date29 July 2024
About the buyer
NHS England runs the NHS in England, and buys as a central healthcare organisation with its own team of procurement professionals. Much of this procurement flows through framework agreements and the Crown Commercial Service. Seven regional teams support the commissioning of healthcare services across the country. The central commercial function that develops procurement strategy for the whole NHS sits here.
Clinical services are commissioned directly or through the Provider Selection Regime.
Over the past 5 years, most of NHS England's contract awards have been in education and training, health and social work, and IT services.
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
14 similar open tenders
See more open tenders related to Pharmaceutical products.
- Open tender
NP93827 Seasonal Influenza Vaccine
- Open tender
NP93827 Seasonal Influenza Vaccine
- Open tender
Hepatitis C Medicines
- Open tender
NHS National Framework for Lenvatinib
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
Related topics
Topics related to NHS National Framework for Transition products commencing 1 October 2024, ranked by notice volume.
- 45,342£7.9tn
Related buyers
Buyers similar to NHS England.
- 511£249.0m
- 432£12.3bn
- 409£110.7m
- 390£652.7m
- 331£25.1bn
- 311£1.3bn
- 293£1.6bn
- 279£3.0bn
- 154£116.5m
- 146£999.8m
Finding public sector work shouldn't be hard
Make your next tender search effortless with Stotles. Set up alerts, find decision maker contacts and never miss a good-fit opportunity again.